Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age

被引:9
作者
Ahn, JiYoon B. [1 ,2 ]
Bae, Sunjae [1 ,2 ]
Schnitzler, Mark [3 ]
Hess, Gregory P. [4 ]
Lentine, Krista L. [3 ]
Segev, Dorry L. [1 ,2 ]
McAdams-DeMarco, Mara A. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] St Louis Univ, Sch Med, Ctr Abdominal Transplantat, St Louis, MO USA
[4] Drexel Univ, Coll Med, Dept Emergency Med, Philadelphia, PA 19104 USA
关键词
RENAL-TRANSPLANTATION; LONG-TERM; MYCOPHENOLATE-MOFETIL; MULTIPLE IMPUTATION; RISK-FACTORS; MELLITUS; TACROLIMUS; SURVIVAL; THERAPY; IMMUNOSUPPRESSION;
D O I
10.1097/TXD.0000000000001260
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Posttransplant diabetes (PTD), a major complication after kidney transplantation (KT), is often attributable to immunosuppression. The risk of PTD may increase with more potent steroid maintenance and older recipient age. Methods. Using United States Renal Data System data, we studied 12 488 adult first-time KT recipients (2010-2015) with no known pre-KT diabetes. We compared the risk of PTD among recipients who underwent early steroid withdrawal (ESW) versus continued steroid maintenance (CSM) using Cox regression with inverse probability weighting to adjust for confounding. We tested whether the risk of PTD resulting from ESW differed by recipient age (18-29, 30-54, and >= 55 y). Results. Of 12 488, 28.3% recipients received ESW. The incidence rate for PTD was 13 per 100 person-y and lower among recipients who received ESW (11 per 100 person-y in ESW; 14 per 100 person-y in CSM). Overall, ESW was associated with lower risk of PTD compared with CSM (adjusted hazard ratio [aHR] = (0.72)0.79(0.86)), but the risk differed by recipient age (P-interaction = 0.09 for comparison between recipients aged 18-29 and those aged 30-54; P-interaction = 0.01 for comparison between recipients aged 18-29 and those aged >= 55). ESW was associated with lower risk of PTD among recipients aged >= 55 (aHR = (0.62)0.71(0.81)) and those aged 30-54 (aHR = (0.73)0.83(0.95)), but not among recipients aged 18-29 (aHR = (0.81)1.18(1.72)). Although recipients who received ESW had a higher risk of acute rejection across the age groups (adjusted odds ratio = (1.01)1.17(1.34)), recipients with no PTD had a lower risk of mortality (aHR = (0.58)0.66(0.74)). Conclusions. The beneficial association of ESW with decreased PTD was more pronounced among recipients aged >= 55, supporting an age-specific assessment of the risk-benefit balance regarding ESW.
引用
收藏
页数:8
相关论文
共 53 条
[31]   Withdrawal of steroids from triple-drug therapy in kidney transplant patients [J].
Matl, I ;
Lácha, J ;
Lodererová, A ;
Simová, M ;
Teplan, V ;
Lánská, V ;
Vítko, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1041-1045
[32]   Diabetes mellitus after renal transplantation - As deleterious as non-transplant-associated diabetes? [J].
Miles, AMV ;
Sumrani, N ;
Horwitz, R ;
Homel, P ;
Maursky, V ;
Markell, MS ;
Distant, DA ;
Hong, JH ;
Sommer, BG ;
Friedman, EA .
TRANSPLANTATION, 1998, 65 (03) :380-384
[33]   Posttransplantation diabetes - A systematic review of the literature [J].
Montori, VM ;
Basu, A ;
Erwin, PJ ;
Velosa, JA ;
Gabriel, SE ;
Kudva, YC .
DIABETES CARE, 2002, 25 (03) :583-592
[34]   Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review [J].
Pascual, Julio ;
Royuela, Ana ;
Galeano, Cristina ;
Crespo, Marta ;
Zamora, Javier .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) :825-832
[35]   A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation [J].
Pascual, Julio ;
Galeano, Cristina ;
Royuela, Ana ;
Zamora, Javier .
TRANSPLANTATION, 2010, 90 (04) :343-349
[36]   Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine [J].
Pelletier, RP ;
Akin, B ;
Ferguson, RM .
CLINICAL TRANSPLANTATION, 2006, 20 (01) :10-18
[37]   A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation [J].
Pirsch, JD ;
Miller, J ;
Deierhoi, MH ;
Vincenti, F ;
Filo, RS .
TRANSPLANTATION, 1997, 63 (07) :977-983
[38]   Risk factors and incidence of posttransplant diabetes mellitus [J].
Reisæter, AV ;
Hartmann, A .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (5A) :8S-18S
[39]   Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation [J].
Revanur, VK ;
Jardine, AG ;
Kingsmore, DB ;
Jaques, BC ;
Hamilton, DH ;
Jindal, RM .
CLINICAL TRANSPLANTATION, 2001, 15 (02) :89-94
[40]   Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and Daclizumab induction in renal transplantation [J].
Rostaing, L ;
Cantarovich, D ;
Mourad, G ;
Budde, K ;
Rigotti, P ;
Mariat, C ;
Margreiter, R ;
Capdevilla, L ;
Lang, P ;
Vialtel, P ;
Ortuño-Mirete, J ;
Charpentier, B ;
Legendre, C ;
Sanchez-Plumed, J ;
Oppenheimer, F ;
Kessler, M .
TRANSPLANTATION, 2005, 79 (07) :807-814